Certificate in terms of Regulation 74(5) SEBI (Depositories and Participants) Regulations,2018 for the quarter and half-year ended September 2025.
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India has submitted a certificate from its Registrar and Share Transfer Agent (RTA), MUFG Intime India, as required under SEBI's Depositories and Participants Regulations. The certificate confirms that all securities received from depository participants for dematerialisation during the quarter and half-year ended September 30, 2025 were properly processed, accepted or rejected by the RTA, and the corresponding physical certificates were mutilated and cancelled. The depositories' names have been substituted as registered owners in the company's member register within SEBI's prescribed timelines. The RTA also noted that no rematerialisation requests were received during the period.
This is a routine regulatory compliance filing with no material business or financial impact. It does not affect share price, dividends, or shareholder rights — it simply confirms that Novartis India's share dematerialisation activities were processed properly during the quarter.